Aller au contenu principal
Profil bibliographique

Arto Yuwono Soeroto

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

81Publications signalées
1177Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Tuberculosis Research and EpidemiologyCOVID-19 Clinical Research StudiesFungal Biology and ApplicationsLong-Term Effects of COVID-19Diagnosis and treatment of tuberculosis

Les publications récentes

Accès ouvert 2026 article OpenAlex

Is targeted next generation sequencing for drug-resistant tuberculosis feasible in a high-burden setting: a qualitative study from Indonesia

Salma N. Annisa, Almira Alifia, Alamanda Larasmanah, Nurlaila S. Ramadhani et autres

OBJECTIVES: Targeted next-generation sequencing (tNGS) offers promise in the rapid detection of drug-resistant tuberculosis (DR-TB) directly from sputum. While pilot studies on tNGS are emerging, there is limited empirical qualitative evidence on tNGS implementation. This study, therefore, aimed to explore the experiences …

id, nl, gb, nz (code pays fourni par la source)

0 citations BMJ Open
Accès ouvert 2026 article OpenAlex

Characteristics of Primary and acquired multidrug-resistant tuberculosis patients in West Java, Indonesia

Prayudi Santoso, Alya Putri Khairani, Eppy Buchori Aristiady, Lidya Chaidir et autres

Objectives: The increasing incidence of primary multidrug-resistant tuberculosis (MDR-TB) creates a new burden in national tuberculosis (TB) control. Understanding the characteristics of primary MDR-TB aids in predicting its spread. This study aimed to determine the differences in characteristics of primary and acquired …

id (code pays fourni par la source)

0 citations IJID Regions
Accès ouvert 2026 article OpenAlex

Pretreatment out-of-pocket costs for people with drug-resistant tuberculosis in Bandung, Indonesia

Bony Wiem Lestari, Silvi Indriani, Adriana Viola Miranda, Dyah Ayu Nur Safira et autres

BACKGROUND: People with drug-resistant tuberculosis (DR-TB) experience multiple visits to healthcare providers before DR-TB diagnosis and treatment. Our study aimed to quantify pretreatment direct costs and factors associated with higher costs among people with DR-TB. METHODS: Our cross-sectional study aimed to recruit …

id (code pays fourni par la source)

0 citations PLoS ONE
Accès ouvert 2026 article OpenAlex

Targeted next-generation sequencing for direct drug-resistant tuberculosis detection in sputum samples in Indonesia: an implementation study (2024–25)

Bony Wiem Lestari, Rifky Waluyajati Rachman, Rahmah Aulia Zahra, Alamanda Larasmanah et autres

Background: The availability of targeted Next Generation Sequencing (tNGS) for drug-resistant tuberculosis (DRTB) is a major advance in TB diagnostics, but its optimal implementation, yield, and cost in high TB-incidence settings remain unclear. We aimed to evaluate tNGS in relation to laboratory …

id, nz, nl, gb (code pays fourni par la source)

2 citations The Lancet Regional Health - Southeast Asia
Accès ouvert 2026 dissertation OpenAlex

RISK6 as a Translational Host Transcriptomic Signature for Tuberculosis Diagnosis, Treatment Monitoring, and Risk Stratification

Chrispian Mamudi, Purnamawati -, Panca Andana, Prayudi Santoso et autres

Tuberculosis (TB) remains a leading cause of infectious mortality worldwide, reflecting persistent gaps in diagnosis, risk stratification, and treatment monitoring. Host RNA transcriptomic signatures have emerged as promising tools for capturing dynamic immune responses across the TB disease spectrum. Among these, the …

id (code pays fourni par la source)

1 citation Pathogens
Accès ouvert 2026 article OpenAlex

Factors Predicting successful treatment outcome with novel BPaLM/BPaL regimen in individuals with drug-resistant tuberculosis: Experience From Indonesia

Arto Yuwono Soeroto, Aga Purwiga, Hendarsyah Suryadinata, Bachti Alisjahbana et autres

BACKGROUND AND AIMS: Drug-resistant tuberculosis (DR-TB) poses a serious challenge in Indonesia, with treatment success rates of only 50%. The BPaLM/BPaL regimen represents the latest therapeutic approach, offering shorter duration, minimal side effects, and treatment success rates of 84-90%. An operational research …

id (code pays fourni par la source)

2 citations PLoS ONE
Accès ouvert 2026 preprint OpenAlex

RISK6 as a Translational Host Transcriptomic Signature for Tuberculosis Diagnosis, Treatment Monitoring, and Risk Stratification

Chrispian Mamudi, Arto Yuwono Soeroto, Lidya Chaidir, Purnamawati - et autres

Tuberculosis (TB) remains a leading cause of infectious mortality worldwide, reflecting persistent gaps in diagnosis, risk stratification, and treatment monitoring. Host RNA transcriptomic signatures have emerged as promising tools for capturing dynamic im-mune responses across the TB disease spectrum. Among these, the …

id (code pays fourni par la source)

0 citations Preprints.org
Accès ouvert 2025 article OpenAlex

Chronic Respiratory Symptoms among TB Survivors in a High-TB Burden Setting in Indonesia: A Preliminary Study

Intan Mauli Warma Dewi, Raden Nabilah Putri Fauziyyah, Iceu Dimas Kulsum, Bony Wiem Lestari et autres

Background: Tuberculosis (TB) affects over 10 million people worldwide and causes more than 1.4 million deaths in 2019. Despite improvements in TB treatment, many TB survivors experience ongoing health problems. Post-TB lung disease (PTLD) affects 30-60% of treated patients, leading to chronic …

id (code pays fourni par la source)

1 citation Jurnal Respirologi Indonesia
Accès ouvert 2025 article OpenAlex

Whole genome sequencing reveals novel resistance-conferring mutations and large genome deletions in drug-resistant Mycobacterium tuberculosis isolates from Indonesia

Htin Lin Aung, Lidya Chaidir, Dian Ayu Eka Pitaloka, Narender Kumar et autres

OBJECTIVE: This study evaluated drug resistance profiles of Mycobacterium tuberculosis (Mtb) isolates in West Java, Indonesia through phenotypic and genomic approaches. METHODS: We performed phenotypic drug-susceptibility testing (DST), coupled with whole-genome sequencing (WGS) of 142 Mtb isolates identified as RIF-R (Rifampicin resistant) …

nz, id, gb, nl (code pays fourni par la source)

3 citations Journal of Global Antimicrobial Resistance
Accès ouvert 2025 article OpenAlex

High Rates of Mortality During Drug-Resistant Tuberculosis Treatment Among Individuals With Diabetes Mellitus and Low Body Mass Index

Lara D Veeken, Iceu Dimas Kulsum, Bony Wiem Lestari, Prayudi Santoso et autres

Abstract Background Diabetes is a risk factor for mortality during rifampicin-resistant tuberculosis (RR-TB) treatment, but whether its impact differs by nutritional status is unknown. We estimated the effect of diabetes and its interaction with low body mass index (BMI) (ie, <18.5 kg/m2) …

nl, us, id, kh, gb (code pays fourni par la source)

3 citations Open Forum Infectious Diseases

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.